Colette Condorcita Schmitt

When clinicians, policymakers, or families confront the realities of substance use disorder (SUD), the conversation often focuses narrowly on addiction itself—cravings, relapse cycles, or treatment programs—but the data reveal a more nuanced story. SUD rarely arises in isolation. Deeply correlated with neurodivergence and trauma, the overlap of these neuro-phenomenology patterns reveals shared pathways of coping and risk. Adults with ADHD are about twice as likely to develop a substance use...

In a time when diversity, equity, and inclusion (DEI) efforts are not just stalled but actively being dismantled—from government bans to corporate rollbacks—it’s critical to examine what’s at stake.  Policies that once aimed to make workplaces more inclusive are being stripped away, especially in the U.S., where political movements seek to eliminate DEI initiatives entirely.  Under the influence of figures like Donald Trump and his allies, entire frameworks meant to support marginalized...

The psychedelic industry is evolving quickly. What was once confined to underground circles and sacred ceremonies is now entering the mainstream through clinical trials, legal retreat centers, an expanding underground, and state-licensed therapy programs. More people than ever are seeking healing through substances like psilocybin, MDMA, and ayahuasca. However, as access expands, so does the complexity. Words like facilitator, shaman, and therapist are often used interchangeably, sometimes...